Drugs / IAP086
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07596888 | Jun 2026 → May 2027 expected | HIV infectious disease | University of North Carolina, Chapel Hill | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IAP086 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07596888 ↗ |
| Route | Intravenous | “The study will evaluate single ascending doses of IAP086 by intravenous (IV) infusion” NCT07596888 ↗ |